Clinical Trials Browser

Completed × Inflammatory Breast Neoplasms × Semaxinib × Clear all

NCT00005822 2010-06-11

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms